News
The section includes updates and press releases from hepCoalition and partner organizations. Includes highlights of upcoming events, actions, and important meetings.
Calendar
Curated list of key international conferences and meetings related to hepatitis C, substance user health, and harm reduction.
Partner News
The section includes updates from partner organizations on related advocacy efforts.
Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEPFAR COPs
PEPFAR Watch webinar co-hosted by Treatment Action Group, World Hepatitis Alliance, Harm Reduction International, and the International Drug Policy Consortium. More
The Asia-Pacific Region Has the World’s Highest Burden of Hepatitis B
In an issue brief, amfAR’s TREAT Asia program responds to this urgent global public health emergency pointing out the scope of the problem and what’s needed for the prevention, care, and treatment of people at risk for or impacted by HBV. More
Press Releases
Press releases from hepCoalition and partner organizations.
TAG Welcomes Addition of Ravidasvir to WHO Essential Medicines List for Treatment of Hepatitis C Virus
Ravidasvir is the first HCV cure to be developed through South-South collaboration and with funding and clinical support from non-profit organizations. It is now recommended for use in combination with sofosbuvir as an alternative pangenotypic DAA. More
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Four years after MPP and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers, generic G/P is not available anywhere. More
